clinical trial · NCT06038474
Descartes-08 for Patients With Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)Descartes-08
brief summary
This is a Phase II study to evaluate the safety, tolerability and manufacturing feasibility of Descartes-08 CAR T-cells in patients with Systematic Lupus erythematosus (SLE).
started
Feb 12, 2024
primary completion
Dec 1, 2026
completion
Dec 1, 2027
last updated
Mar 27, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol